Target intelligence / Profile preview

H3 histone pseudogene 25 (H3P25)

Target: H3P25
Molecular classification: Other (Pseudogene)

Overview

H3 histone pseudogene 25 (H3P25) is classified as a pseudogene relating to the histone H3 family. Unlike functional histone H3 variants, such as H3.1, H3.2, H3.3, or H3.Y, which are involved in nucleosome structure and epigenetic regulation, pseudogenes generally do not produce functional proteins and typically lack biological activity[1][2]. There is no evidence to suggest that H3 histone pseudogene 25 serves as a therapeutic target, is involved in disease, or interacts with any drugs. Pseudogenes are usually considered as non-functional remnants of gene duplication or retrotransposition events and do not play a known biological or pathological role.

Other names: H3P25H3 histone pseudogene 25

Beyond the preview

Go deeper on H3 histone pseudogene 25 (H3P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H3 histone pseudogene 25 (H3P25).

Explore the full profile